Clinical Trials Browser

Interventional × Ribavirin × 1 year × Clear all

NCT01309490 2025-07-29

Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients

Phase 1/2 Terminated

Other solid neoplasm

Malignant Solid Tumor

NCT02940496 2025-07-15

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Phase 2 Completed

15 enrolled 8 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular